What You Should Know:
– Reveleer, a technology platform for value-based care announced its acquisition of Novillus, a company known for its insight-driven care gap management and frictionless provider engagement solutions.
– The strategic acquisition significantly enhances Reveleer’s suite of clinical intelligence and quality improvement tools, aiming to empower health plans and providers to collaborate more effectively for improved patient outcomes, stronger regulatory compliance, and better financial performance.
Strengthening Payer-Provider Collaboration
As the healthcare landscape increasingly emphasizes alignment between payers and providers for success in value-based care, this acquisition accelerates Reveleer’s strategy. The integration of Novillus’ technology bolsters Reveleer’s ability to deliver modern, easy-to-use solutions that facilitate seamless collaboration on critical initiatives like risk adjustment, quality improvement, and other patient-centric efforts. The core aim is to break down silos and foster a more unified approach between health plans and the providers delivering care.
Expanding Capabilities with Novillus Technology
Novillus brings valuable assets to the Reveleer platform, particularly in identifying and addressing care gaps at the provider group level to enhance targeted education and performance improvement. Key capabilities being integrated include:
- Insight-Driven Care Gap Management: Pinpointing opportunities to improve patient care.
- Frictionless Provider Engagement: Utilizing advanced workflows, enhanced AI automation, and real-time roster management to streamline interactions.
- Clean Provider Data Solution: Strengthening regulatory compliance, especially concerning the federal No Surprises Act and other mandates, by improving provider directory accuracy, reducing risk, enhancing patient satisfaction, and minimizing provider abrasion.
“By acquiring Novillus, we’re accelerating our strategy of aligning payers and providers to improve health outcomes through faster care gap closure,” said Jay Ackerman, CEO of Reveleer.“ This acquisition strengthens our platform’s ability to deliver unmatched AI-powered quality and clinical intelligence solutions, while helping our customers not only meet, but exceed their goals for Star performance, risk adjustment accuracy, and care gap closure. All are key areas that drive improved patient outcomes, reduce cost of care, and improve financial success.”
